September 14, 2026

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 17.48% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands as a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in South Jordan, Utah, the company..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Competitive Healthcare Landscape with Cautious Optimism

Avantor, Inc. (NYSE: AVTR) stands as a key player in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in Radnor, Pennsylvania, and with a sprawling global..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising 23.28% Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD) has recently captured the attention of investors with its innovative approach in the healthcare sector, specifically within the biotechnology industry. Boasting a market capitalization of..

ICON plc (ICLR) Stock Analysis: Unpacking a 9.6% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading clinical research organization, stands at an intriguing juncture for investors seeking exposure in the healthcare sector. With a market capitalization of $13.06 billion, the..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 31% Upside Potential Amid Healthcare Innovation

Koninklijke Philips N.V. (NYSE: PHG), a Dutch healthcare technology leader, presents a compelling opportunity for investors with a potential upside of nearly 31% based on current analyst ratings. Operating at..

Teleflex Incorporated (TFX) Stock Analysis: A 17.22% Potential Upside Amidst Strong Revenue Growth

Investors eyeing opportunities in the healthcare sector may find Teleflex Incorporated (NYSE: TFX) an intriguing option, especially with an enticing potential upside of 17.22% based on current analyst targets. This..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 10.20% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry and boasts a market capitalization of $25.27 billion. The company’s current..

Quest Diagnostics (DGX): Investor Outlook Highlights 4.98% Potential Upside

As investors navigate the intricate landscape of healthcare equities, Quest Diagnostics Incorporated (NYSE: DGX) emerges as a noteworthy consideration. With its roots entrenched in the diagnostics and research industry, Quest..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Promising 89% Upside Potential in the Biotech Sector

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology industry, is capturing investor attention with its compelling growth story and substantial upside potential. Based in Australia, Telix is..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 9.23% Potential Upside with Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB) remains a captivating prospect for investors seeking exposure in the healthcare sector, particularly within the pharmaceutical landscape. With its strategic focus on cutting-edge therapies and robust..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings and 14% Upside Potential

For investors eyeing opportunities in the healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling proposition. With its robust $140.7 billion market cap, Danaher stands as a titan in the..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating a 33.64% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Silver Spring, Maryland, the company..

Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and a 14.85% Upside Potential

Cencora, Inc. (COR), a healthcare titan in the medical distribution industry, continues to capture investor attention with its robust market presence and promising growth prospects. With a market capitalization of..

Insulet Corporation (PODD) Stock Analysis: Eyeing a 30% Upside Amid Strong Revenue Growth

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) an intriguing prospect, especially given its current market position and potential upside. With a robust..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth in Healthcare Diagnostics with a 5.54% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV) continues to make compelling strides in the healthcare sector, showcasing a promising trajectory for investors seeking exposure to the diagnostics and research industry. With a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 12.99% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the global pharmaceutical landscape, stands at an intriguing juncture for investors. Established in 1901 and headquartered in Tel Aviv-Yafo, Israel,..

Abbott Laboratories (ABT) Investor Outlook: Strong Buy Ratings and 18% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare and medical devices industry, presents a compelling opportunity for investors seeking growth and stability. With a market capitalization of $176.41 billion,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 25.36% Potential Upside in the Healthcare Giant

UnitedHealth Group Incorporated (NYSE: UNH) stands as a behemoth in the healthcare industry with a market capitalization of $340.27 billion. As a leader in healthcare plans, UnitedHealth Group offers a..

Waystar Holding Corp. (WAY) Stock Analysis: A Strong Buy with 41.9% Upside Potential

For investors seeking opportunities in the healthcare technology sector, Waystar Holding Corp. (NASDAQ: WAY) presents itself as a compelling option. With a significant potential upside of 41.9% based on analyst..

Repligen Corporation (RGEN) Stock Analysis: Strong Buy Ratings and 14.71% Upside Potential

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in medical instruments and supplies, specifically focusing on bioprocessing technologies. With a market capitalization of $9.32 billion and..

Search

Funds

September 14, 2026

Search

Funds

September 14, 2026

FTSE 100

Funds